AstraZeneca PLC (LSE:AZN) shares spiked higher on Tuesday afternoon on reports that the boss of the UK pharmaceutical giant wants to move the company to the US.
CEO Pascal Soriot wants to the FTSE 100's largest company to leave the UK due to his frustration with restrictions on medicines and pricing under the NHS, according to a report in The Times.
The Frenchman does not like the restrictions imposed by NICE (the National Institute for Health and Care Excellence), which advises the NHS on which treatments, including medicines, are cost-effective and should be funded.
Shares in AZ jumped 2.6% after the news emerged.